A study comparing triple therapy with Fluticasone furoate/Umeclidinium/Vilanterol to inhaled corticosteroids in patients with chronic obstructive pulmonary disease
Latest Information Update: 23 Dec 2020
Price :
$35 *
At a glance
- Drugs Fluticasone furoate/umeclidinium/vilanterol (Primary) ; Glycopyrrolate/indacaterol; Olodaterol/tiotropium bromide; Umeclidinium/vilanterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 23 Dec 2020 New trial record